Suchergebnisse - Huma Dar

Long‐term benefit from adjuvant tamoxifen therapy for ER + HER2− breast cancer by PR positivity von Anna E. Nordenskjöld, Magdalena Ríos‐Romero, Huma Dar, Tommy Fornander, Gizeh Perez‐Tenorio, Helena Fohlin, Olle Stål, Julia Tutzauer, Linda S. Lindström

Volltext

Progesterone receptor ( PR ) intra‐tumor heterogeneity in premenopausal breast cancer: A secondary analysis of a randomized trial von Oscar Danielsson, Huma Dar, Gizeh Perez‐Tenorio, Anna Nordenskjöld, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Johan Hartman, Nicholas P. Tobin, Annelie Johansson, Linda S. Lindström

Volltext